Investigating how an anti-aging molecule can protect the retina in diabetic patients
Official title: Anti-Aging Molecule Sirt6 in Neuroprotection in Diabetic Retina
Funded at University of Texas Med Br Galveston · NIH-11092848 · Data updated 2026-11-12
This study is looking at how a special molecule called Sirt6 might help protect the eyes of people with diabetes from damage that can lead to vision loss, with the goal of finding new ways to keep your eyesight healthy.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Texas Med Br Galveston NIH-funded |
| Lab location | 1 site (Galveston, United States) |
| Project start | May 1, 2023 |
| Project end | April 30, 2028 |
| Funding year | 2025 |
| Award (this year) | $541,883 |
| NIH project number | 5R01EY034616-03 |
| Project ID | NIH-11092848 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are adults with diabetic retinopathy who are at risk of vision loss.
✕Less likely to help
Patients without diabetes or those who do not have diabetic retinopathy may not benefit from this research.
What this research studies
This research focuses on diabetic retinopathy, a leading cause of blindness in working-age adults, and aims to understand how the anti-aging molecule Sirt6 can protect retinal neurons from damage. The study will explore the mechanisms behind retinal ganglion cell injury and axonal degeneration in diabetes, which are critical to vision loss. By identifying novel strategies to limit this injury, the research seeks to develop new treatments that preserve vision in diabetic patients. The approach includes both animal models and patient studies to gather comprehensive data on the effects of Sirt6 in the retina.
Why it matters
Potential benefit: If successful, this research could lead to new therapies that prevent vision loss in diabetic patients by protecting retinal neurons.
How similar studies have gone: While there have been studies on the role of Sirt6 in other conditions, this specific application in diabetic retinopathy is relatively novel and untested.
Where this research is happening
-
University of Texas Med Br Galveston
Galveston, United States Active
Researchers
- Principal investigator: Zhang, Wenbo — University of Texas Med Br Galveston
- Study coordinator: Zhang, Wenbo
Related research
Other NIH-funded projects on the same topics.
-
Aging Well with HIV: Alcohol, Risk Reduction, and Education Center (AWAR3E)
A center at Yale is exploring how aging with HIV interacts with alcohol use to create inflammation and frailty, with the goal of finding biomarkers and potential treatments.
-
Cognitive SuperAging: Exploring why some octogenarians stay sharp in memory
This NIH grant studies why a small group of people aged 80+ keep memory skills as good as much younger people, hoping to understand how to protect memory as we age.
-
Biological aging across the lifespan through a national high school-to-adult study
This grant uses a long-running national study of students and adults to collect saliva biomarkers of aging, alongside surveys, to understand how aging markers relate to health and life experiences.
-
Understanding how aging and Alzheimer’s affect how people make tough choices
This NIH grant studies how aging and Alzheimer’s risk change how people decide between immediate and delayed rewards and risky options, with the goal of helping older adults stay financially and healthwise safer.
-
Understanding how brain resilience and multiple brain pathologies influence aging and Alzheimer's disease
A long-term study follows older adults to learn how resilience to brain changes helps reduce dementia risk and what biological factors are linked to better cognitive aging.
-
National Neighborhood Data Archive helps researchers study aging health in U.S. neighborhoods
A nationwide data resource will help researchers understand how where people live affects health and aging, with a focus on respiratory illnesses in older adults.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.